Trial Profile
Effect of combination of caspofungin and cotrimoxazole for treatment of severe pneumocystis pneumonia in patients with solid organ transplant and HIV-infection.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2015
Price :
$35
*
At a glance
- Drugs Caspofungin (Primary) ; Cotrimoxazole (Primary)
- Indications Pneumocystis pneumonia
- Focus Therapeutic Use
- 11 Feb 2015 New trial record